Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO 90100 vs Betesil in Psoriasis Vulgaris
NCT02518048Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Aug 2015
- Primary completion
- Jan 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of calcipotriol in Psoriasis vulgaris (PV), sponsored by LEO Pharma. Started Aug 2015; status: completed.
02
Drugs
calcipotriol
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT02518048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02518048.